Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
89bio (ETNB)
NASDAQ:ETNB
89bio (ETNB) Stock Price & Analysis
617 Followers
ETNB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.58 - $22.93
Previous Close$8.4
Volume1.11M
Average Volume (3M)1.60M
Market Cap
$635.36M
Enterprise Value$408.30M
Total Cash (Recent Filing)$251.93M
Total Debt (Recent Filing)$24.87M
Price to Earnings (P/E)-4.2
Beta1.27
Next Earnings
Mar 20, 2024EPS Estimate
-$0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.00
Shares Outstanding75,638,516
10 Day Avg. Volume1,068,731
30 Day Avg. Volume1,597,587
Standard Deviation0.26
R-Squared0.03
Alpha-0.00162
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.22
Forecast
1Y Price Target
$29.17Price Target Upside247.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
89bio News
Ownership Overview
0.00% Insiders
15.59% Mutual Funds
63.57% Other Institutional Investors
20.84% Public Companies and Individual Investors
ETNB FAQ
What was 89bio’s price range in the past 12 months?
89bio lowest stock price was $6.58 and its highest was $22.93 in the past 12 months.
What is 89bio’s market cap?
Currently, no data Available
When is 89bio’s upcoming earnings report date?
89bio’s upcoming earnings report date is Mar 20, 2024 which is in 108 days.
How were 89bio’s earnings last quarter?
89bio released its earnings results on Nov 08, 2023. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.526 by $0.076.
Is 89bio overvalued?
According to Wall Street analysts 89bio’s price is currently Undervalued.
Does 89bio pay dividends?
89bio does not currently pay dividends.
What is 89bio’s EPS estimate?
89bio’s EPS estimate is -$0.51.
How many shares outstanding does 89bio have?
89bio has 75,638,520 shares outstanding.
What happened to 89bio’s price movement after its last earnings report?
89bio reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.526. Following the earnings report the stock price went down -4.857%.
Which hedge fund is a major shareholder of 89bio?
Among the largest hedge funds holding 89bio’s share is RA Capital Management. It holds 89bio’s shares valued at 176M.
---
89bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.17 (247.26% Upside)
$29.17 (247.26% Upside)
Blogger Sentiment
Bullish
ETNB Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 30.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.69%
12-Months-Change
Fundamentals
Return on Equity
-44.97%
Trailing 12-Months
Asset Growth
129.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
89bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
---
Top 5 ETFs holding ETNB
Vanguard Total Stock Market ETF
$13.73M
Vanguard Health Care ETF
$1.29M
Vanguard U.S. Momentum Factor ETF
$302.95K
Purpose Global Innovators Fund
$155.25K
Vanguard Russell 3000 ETF
$28.79K
Up to five ETFs with an Outperform Smart Score that hold ETNB. The ETFs are listed according to market value of ETNB within the ETF
---